CALCULLI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 7.046
EU - Europa 6.338
AS - Asia 6.093
AF - Africa 419
SA - Sud America 338
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.248
Nazione #
US - Stati Uniti d'America 6.976
VN - Vietnam 1.689
SG - Singapore 1.664
GB - Regno Unito 1.655
CN - Cina 1.593
IT - Italia 1.157
DE - Germania 772
SE - Svezia 748
UA - Ucraina 456
FR - Francia 399
HK - Hong Kong 376
IN - India 323
RU - Federazione Russa 318
BR - Brasile 233
IE - Irlanda 231
CH - Svizzera 145
EE - Estonia 125
ZA - Sudafrica 124
TG - Togo 118
JP - Giappone 113
NL - Olanda 95
FI - Finlandia 93
NG - Nigeria 52
AR - Argentina 51
CI - Costa d'Avorio 49
SC - Seychelles 49
CA - Canada 40
BD - Bangladesh 36
KR - Corea 35
JO - Giordania 34
PH - Filippine 34
TR - Turchia 28
IQ - Iraq 26
AT - Austria 24
BE - Belgio 23
TH - Thailandia 23
BG - Bulgaria 20
PL - Polonia 20
ID - Indonesia 15
MX - Messico 15
CL - Cile 14
EC - Ecuador 14
LB - Libano 14
TW - Taiwan 14
AU - Australia 11
GR - Grecia 11
SA - Arabia Saudita 11
IR - Iran 10
ES - Italia 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
PY - Paraguay 7
UZ - Uzbekistan 7
EG - Egitto 6
MY - Malesia 6
CZ - Repubblica Ceca 5
NP - Nepal 5
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
JM - Giamaica 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
AZ - Azerbaigian 2
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
EU - Europa 1
GA - Gabon 1
IS - Islanda 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
Totale 20.239
Città #
Southend 1.506
Singapore 1.094
Ashburn 669
Chandler 612
Dong Ket 479
Fairfield 453
Santa Clara 394
San Jose 360
Hong Kong 356
Jacksonville 315
Princeton 298
Ho Chi Minh City 276
Wilmington 272
Hanoi 270
Dublin 230
Beijing 224
Woodbridge 202
Seattle 189
Ann Arbor 179
Houston 179
Boardman 161
Cambridge 153
Los Angeles 144
New York 141
Lauterbourg 140
Padova 138
Westminster 138
Nanjing 135
Bern 132
Lomé 118
Tokyo 105
Berlin 97
Helsinki 90
Hefei 89
Medford 83
Jinan 75
Milan 72
Shenyang 69
Dallas 64
Bologna 61
Saint Petersburg 60
Turin 57
Mülheim 52
Tianjin 52
Buffalo 51
Abeokuta 49
Abidjan 49
Rome 45
Hebei 44
Haiphong 43
Nanchang 42
Redondo Beach 42
Bremen 39
Florence 39
Da Nang 37
Changsha 36
Mahé 36
San Diego 35
Amman 34
Des Moines 34
Guangzhou 34
Jiaxing 34
Shanghai 34
Frankfurt am Main 33
Dearborn 30
Grafing 28
Munich 28
Zhengzhou 28
São Paulo 26
Yubileyny 26
Phoenix 25
Olalla 24
Norwalk 23
Falkenstein 22
Brussels 21
Verona 21
Redwood City 19
Seoul 19
Sofia 19
The Dalles 19
Falls Church 18
Kunming 18
Ningbo 18
Atlanta 17
Can Tho 17
Chengdu 17
Xi'an 17
Hangzhou 16
Orem 16
Redmond 16
Taiyuan 16
Brooklyn 15
Wuhan 15
Hải Dương 14
Council Bluffs 13
London 13
Nuremberg 13
San Francisco 13
San Venanzo 13
Toronto 13
Totale 12.459
Nome #
Neoplasia papillare intraduttale mucinosa (IMPN) multifocale del pancreas. Caso clinico 724
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 258
Are the New IPMN’s Guideline Effective to Predict the Presence of Invasive IPM Carcinoma? A Single Center Experience. 239
A study of the relationship between idiopathic hyperenzymemia and dyslipidemia. 238
Air in the Wirsung duct. An unusual finding. 236
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 224
Adenocarcinoma del colon e neoplasia intraduttale mucinosa (IPMN) multifocale sincrona del pancreas in un paziente anziano: possibili strategie terapeutiche. 219
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 219
Intraductal papillary mucinous neoplasms: the bologna experience. Lessons learned from 357 cases observed in a tertiary care center 212
Can pancreatic steatosis explain the finding of pancreatic hyperenzymemia in subject with dyslipidemia? 206
A study of the relationship between idiopathic pancreatic hyperenzynemia and dyslipidemia 202
Intraductal Papillary Mucinous Neoplasms: The Bologna Experience 202
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 196
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 193
Autoimmune Pancreatitis Associated with Anisakis Infection 190
Co-morbidities and pancreatic stump treatment after pancreaticoduodenectomy: are they linked to postoperative morbidity? 189
Magnetic resonance cholangiopancreatography in asymptomatic pancreatic hyperenzymemia 189
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 189
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
Adenocarcinoma del colon e neoplasia papillare intraduttale mucinosa multifocale sincrona del pancreas in un paziente anziano. Caso clinico. 188
Branch duct intraductal papillary mucinous neoplasm: validation of Fukuoka 2012 guidelines using a systematic review and meta-analysis 186
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 185
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 185
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 183
Il percorso diagnostico preoperatorio e la preparazione all'intervento chirurgico 178
Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. 178
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 177
Prospective validation of a preoperative risk score model based on pancreatic texture to predict postoperative pancreatic fistula after pancreaticoduodenectomy. 176
Risk Factors in Resected Pancreatic Cancer. A Single Centre Experience 171
Intraductal papillary mucinous neoplasms: the Bologna experience. Lessons learned from 357 cases observed in a tertiary care center 171
Nuove metodiche di trattamento delle fistole pancreatiche: l'utilizzazione di sostanze sclerosanti 169
I tumori cistici del pancreas: aspetti morfologici in TC e RM. 168
Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets 168
Comparison of Clinical Data and Scores of Quality of Life, Anxiety, and Depression in Patients with Different Types of Intraductal Papillary Mucinous Neoplasms: A Prospective Study 167
A prospective study on radiofrequency ablation locally advanced pancreatic cancer. 166
Cystic dystrophy of the duodenal wall is not always associated with chronic pancreatitis. 163
A bizarre abdominal cystic lesion 161
Comparative study between Balthazar computer tomography severità and Mortele modified computer tomography severità index for the assessment of acute pancreatitis. 160
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 159
Prognostic factors in periampullary and pancreatic tumor Resection in elderly patients. 158
Assessment of complications according to the Clavien-Dindo classification after distal pancreatectomy. 156
Preoperatory Gemcitabine and Oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma 156
Sclerosing cholangitis, autoimmune chronic pancreatitis, and situs viscerum inversus totalis. 156
Practical guidelines for acute pancreatitis. 156
Risk Factors for Malignancy of Branch-Duct Intraductal Papillary Mucinous Neoplasms: A Critical Evaluation of the Fukuoka Guidelines With a Systematic Review and Meta-analysis 154
Prevalence of Asymptomatic Intraductal Papillary Mucinous Neoplasms in Healthy and Ill Populations Detected by Ultrasonography: A Single-Center Study of 6353 Outpatients 153
Peripancreatic vascular anatomic variations: impact of radiological diagnosis with multidetector computed tomography (MDTC) on surgical strategy 150
Characterization of neuroendocrine pancreatic cancer with multidetector computer tomography and magneti resonance. 150
Fagan’s normogram: i sit useful in routine clinical setting ? 149
Adenocarcinoma of the pancreas and autoimmune pancreatitis: a challenge for the diagnostic imaging. 149
Long-term survival in neuroendocrine tumors of the pancreas. 148
A study of the relationship between idiopathic pancreatic hyperenzynemia and dyslipidemia. 146
Total pancreatectomy: indications, operative technique, and results : A single centre experience and review of literature 145
Neuroendocrine pancreatic cancer: diagnosis and characterization with spiral computer tomography and nuclear magnetic resonance. 144
Early pancreatic cancer and Peutz-Jeghers syndrome: a case report. 144
Follow-up Strategy for IPMN 143
Italian consensus guidelines for chronic pancreatitis 143
Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience 142
Pancreatic involvement in Von Hippel-Lindau disease: the role of integrated imaging. 141
Usefulness of the Clavien-Dindo classification after pancreaticoduodenectomy 141
Left pancreatectomies and the pancreatic remnant: stapler or handsewn closure ? 141
The Clinical Impact of Splanchnic Ischemia on Patients Affected by Thoracoabdominal Aortic Aneurysms Treated with Fenestrated and Branched Endografts 140
Incidental Cystic Lesion of the Pancreas: What Kind of Management? 138
Useful of Choi’s criteria after neoadjuvant chemoradiotherapy in patients with resectable pancreatic cancer. 138
Serum determination of Ca 19-9 in diagnosing pancreatic cancer: an obituary. 138
The role of intraoperative ultrasonography (IOUS) in pancreatic surgery for multifocal intra ductal papillary mucinous neoplasms (IPMNs) 137
Autoimmune pancreatitis: the classification puzzle. 137
The role of intraoperative ultrasonography (IOUS) in pancreatic surgery for multifocal intra ductal papillary mucinous neoplasms (IPMNs). 136
Neuroendocrine pancreatic cancer: diagnoses and characterization with spiral computed tomography and nuclear magnetic resonance. 135
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 135
New methods of treating the pancreatic fistulas: the use of sclerosing substances 135
Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: An Interim Report of a Prospective Controlled Randomized Study 135
Report of three cases of chronic pancreatic fistulas treated with prolamine as a sclerosing substance following pancreatic resection. 134
Long-Term Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Case Report 134
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 134
Characterization of neuroendocrine pancreatic cancer with multidetector computed tomography and magnetic resonance. 133
Therapeutic management and clinical out come of autoimmune pancreatitis. 133
Prognostic factors in resected pancreatic cancer:a single centre experience 132
Natural history of branch-duct intraductal papillary mucinous neoplasms of the pancreas: a case report. 132
Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study 132
Resezione della coda del pancreas "spleen preserving" ecoguidata per neoplasia intraduttale mucinosa (IPMN) del pancreas. 131
Intraductal Papillary Mucinous Neoplasms and Pancreatic Cancer 130
Late Postpancreatectomy Hemorrhage After Pancreaticoduodenectomy: Is It Possible to Recognize Risk Factors? 130
Synchronous adenocarcinoma of the sigmoid colon and multifocal intraductal papillary mucinous neoplasm of the pancreas in an elderly patient 130
New methods of treating the pancreatic fistulas: the use of sclerosino substances. 128
Varianti anatomiche delle strutture vascolari peripancreatiche: importanza dello studio radiologico mediante TC multidetettore sulla pianificazione chirurgica. 128
Autoimmune pancreatitis: a case mimicking carcinoma. 128
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer 127
The usefulness of a grading system for complications resulting from pancreatic resections: a single center experience. 127
Radiofrequency ablation of unresectable pancreatic carcinoma: preliminary results. 126
Serous Cystic Tumors of the Pancreas: When to Observe and When to Operate 124
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report 124
Sclerosing Cholangitis, Autoimmune Chronic Pancreatitis and Situs Viscerum Inversus Totalis: An Incidental Association? 123
Multifocal intraductal papillary mucinous neoplasms (IPMN) of the pancreas from mild dysplasia to invasive carcinoma: a case report 123
What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study 122
State of art in diagnosis and stadiation of pancreatic cancer with multidetector computer tomography. 120
Pancreatic cystic tumor: radiological diagnosis with multidetector computed tomography and MR. 120
Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging. 120
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer. 120
Pancreatic cystic tumor: radiological diagnosis with multidetector computed tomography and MR 118
Totale 16.305
Categoria #
all - tutte 53.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.093


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021869 0 0 0 0 0 0 0 0 0 0 124 745
2021/20222.614 231 122 120 233 232 148 34 141 71 186 649 447
2022/20233.024 281 472 172 351 204 222 72 162 451 153 269 215
2023/2024733 59 121 55 72 56 172 51 48 15 45 17 22
2024/20252.496 99 423 242 154 586 113 161 55 19 135 39 470
2025/20265.262 375 488 525 355 725 383 508 169 1.109 460 165 0
Totale 20.567